Cargando…

An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial

BACKGROUND: Decisions about new health technologies are increasingly being made while trials are still in an early stage, which may result in substantial uncertainty around key decision drivers such as estimates of life expectancy and time to disease progression. Additional data collection can reduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vervaart, Mathyn, Strong, Mark, Claxton, Karl P., Welton, Nicky J., Wisløff, Torbjørn, Aas, Eline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189722/ https://www.ncbi.nlm.nih.gov/pubmed/34967237 http://dx.doi.org/10.1177/0272989X211068019

Ejemplares similares

General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations
por: Vervaart, Mathyn, et al.
Publicado: (2023)

Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial
por: Heath, Anna, et al.
Publicado: (2021)

Strategies for Efficient Computation of the Expected Value of Partial Perfect Information
por: Madan, Jason, et al.
Publicado: (2014)

Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect Information
por: Fang, Wei, et al.
Publicado: (2021)

Fast efficient computation of expected value of sample information from a probabilistic sensitivity analysis sample: a non-parametric regression approach
por: Strong, Mark, et al.
Publicado: (2013)

Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample: A Fast, Nonparametric Regression-Based Method
por: Strong, Mark, et al.
Publicado: (2015)

Calculating Expected Value of Sample Information Adjusting for Imperfect Implementation
por: Heath, Anna
Publicado: (2022)

Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample: A Nonparametric Regression Approach
por: Strong, Mark, et al.
Publicado: (2013)

Where and When Should Sensors Move? Sampling Using the Expected Value of Information
por: de Bruin, Sytze, et al.
Publicado: (2012)

Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials
por: Flight, Laura, et al.
Publicado: (2021)

Extrapolation of Survival Curves from Cancer Trials Using External Information
por: Guyot, Patricia, et al.
Publicado: (2016)

Cost-effectiveness and value of information analysis of a low-friction environment following skin graft in patients with burn injury
por: Kandiyali, Rebecca, et al.
Publicado: (2020)

Expected value of information in the case of mixed strategies
por: Baio, Gianluca
Publicado: (2013)

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses
por: Welton, Nicky J., et al.
Publicado: (2015)

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
por: Guyot, Patricia, et al.
Publicado: (2012)

Surgical reconstruction is a cost-efficient treatment option for isolated PCL injuries
por: Owesen, Christian, et al.
Publicado: (2017)

Efficient Calculation of Energy Expectation Values in the Path Integral Formalism
por: Grujic, J
Publicado: (2006)

Neural mechanisms underlying expectation-dependent inhibition of distracting information
por: van Moorselaar, Dirk, et al.
Publicado: (2020)

The value of ongoing surveillance on the prevalence of contact sensitization
por: Schuttelaar, M.L.A.
Publicado: (2020)

Maximum Expected Information Approach for Improving Efficiency of Categorical Loudness Scaling
por: Fultz, Sara E., et al.
Publicado: (2020)

Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve
por: Hammitt, James K., et al.
Publicado: (2023)

Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
por: Wisløff, Torbjørn, et al.
Publicado: (2016)

Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
por: Korman, Max, et al.
Publicado: (2018)

Striking balance between expedited review and expecting efficacious anticancer drug and biologics: An ongoing challenge
por: Chary, Krishnan Vengadaragava, et al.
Publicado: (2017)

Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study”
por: Phillippo, David M., et al.
Publicado: (2021)

Network meta‐analysis including treatment by covariate interactions: Consistency can vary across covariate values
por: Donegan, Sarah, et al.
Publicado: (2017)

Genomic Infectious Disease Epidemiology in Partially Sampled and Ongoing Outbreaks
por: Didelot, Xavier, et al.
Publicado: (2017)

Ethics in Online Publications
por: Vervaart, Peter
Publicado: (2014)

Role of Social Media and the Internet in Education
por: Vervaart, Peter
Publicado: (2012)

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data()
por: Wang, Han-I, et al.
Publicado: (2018)

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort
por: Wang, Han-I., et al.
Publicado: (2016)

Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries
por: Lomas, James, et al.
Publicado: (2021)

Value-based tiered pricing for universal health coverage: an idea worth revisiting
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems
por: Woods, Beth, et al.
Publicado: (2021)

Expectation bias and information content
por: Dauter, Zbigniew, et al.
Publicado: (2013)

Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic
por: Madewell, Zachary J, et al.
Publicado: (2021)

Consuming Health Information and Vulnerable Populations: Factors of Engagement and Ongoing Usage
por: Staccini, Pascal, et al.
Publicado: (2022)

Capacity Limits Lead to Information Bottlenecks in Ongoing Rapid Motor Behaviors
por: Moulton, Richard Hugh, et al.
Publicado: (2023)

The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application
por: Espinoza, Manuel A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o6cfnl4egek9vg7t0rg171u6e6